Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
about
Carnitine palmitoyltransferase 2: analysis of membrane association and complex structure with a substrate analogMetabolic imprinting, programming and epigenetics - a review of present priorities and future opportunities.A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone.Electrophysiological mechanisms of the anti-arrhythmic effects of omega-3 fatty acids.An RNA interference screen identifies new avenues for nephroprotection.Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts.Carvedilol in chronic heart failure: past, present and future.On the performance of trimetazidine and vitamin e as pharmacoprotection agents in cyclosporin a-induced toxicity.Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat.Ameliorative effect of trimetazidine on cisplatin-induced hepatotoxicity in rats.Extracellular glycerol regulates the cardiac energy balance in a working rat heart model.
P2860
Q27646285-5B22BA63-558F-45FF-8CEC-A75B5B310730Q34142249-04E1C3D4-9CD0-4640-8603-30B2E24E1949Q35189862-CB9CAAC9-CDFA-4538-B379-958B2F83470AQ37815091-DC70353F-34D5-43E6-BB4A-D32A67BD4B45Q38819738-23599D38-7979-49A0-BEBE-F08EC5F2E1E7Q38841573-BDBDFDA5-3A93-4164-ACF4-B9B10F4D88BAQ40377169-6E7C246F-01B1-4127-9445-624D706B8E38Q40713230-8209D993-AA20-4283-93E3-8675C4F64065Q42581553-1E52018B-8F78-41C1-B4CF-EB678384FD50Q46675081-989DE1D4-7956-4183-AF98-C01F0A25442DQ51487808-261BB25C-8F7F-4367-A148-8B936F8C1BEB
P2860
Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
@ast
Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
@en
type
label
Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
@ast
Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
@en
prefLabel
Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
@ast
Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
@en
P356
P1476
Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
@en
P2093
Alain Grynberg
P304
P356
10.2174/1381612053382061
P577
2005-01-01T00:00:00Z